{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-01T12:20:11.183431+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals (VRTX): Exploring Valuation as Shares Continue Month-Long Moderate Gains - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Exploring Valuation as Shares Continue Month-Long Moderate Gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-01T04:45:48+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxONnhWcExxNnhCV2I3RUtTOWFuWmJrZmNUN2pSQTFHVi1fQmtGcHdIcHltWXlkX0t4RnBrTVhwejJrVFVvS1hld0Fzd0Q5LXFGSG9kZjRiaGREUUhHNUNJTGJ5eklmOFhEeE1iS25NVm44NE43TlNxNXc4RnN5SW1jZXZoUkRuOWFsTmVKMlRyakpBUG9zOE40NQ?oc=5\" target=\"_blank\">Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-10-27T09:43:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Fisher Funds Management LTD Has $5.74 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxQLTJDOEl6Mng2ZGJ6Y2JhaWxYQnFfV3lnTjlOQ2xuY3E5czJYTFdFclBZM2poZW9RUXhqQ1ZMRE1iOHFFVFAxMkQ3MUVnSWV6Y0ZtX19mZjNvSWtBU3YyVHJOQWZ2cG55WFlFdnY0U1U2c09aZjRxbDBkd3g1d09Ca01IWFZEYXNDSnpqN1ZyeUJlejFubmR3WDhDanR4ek9qNk1sMzBtVkR5SkhkTTlUNDVNeFFzM1Z0eDVRdFEwRjVTa3c1bk02N1hoUzZlckVpR0NWRFRDbElGQUFzODZ6YVJHclMxLUREYXV5aFVwd1lSeXBWNWc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQLTJDOEl6Mng2ZGJ6Y2JhaWxYQnFfV3lnTjlOQ2xuY3E5czJYTFdFclBZM2poZW9RUXhqQ1ZMRE1iOHFFVFAxMkQ3MUVnSWV6Y0ZtX19mZjNvSWtBU3YyVHJOQWZ2cG55WFlFdnY0U1U2c09aZjRxbDBkd3g1d09Ca01IWFZEYXNDSnpqN1ZyeUJlejFubmR3WDhDanR4ek9qNk1sMzBtVkR5SkhkTTlUNDVNeFFzM1Z0eDVRdFEwRjVTa3c1bk02N1hoUzZlckVpR0NWRFRDbElGQUFzODZ6YVJHclMxLUREYXV5aFVwd1lSeXBWNWc?oc=5\" target=\"_blank\">Fisher Funds Management LTD Has $5.74 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-11-01T11:05:14+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOd1czMURoTDVhYjZSSFRDaFdIUEU1MjdxUUhIdXNaeU1IVUlvdU5RZFhtaHBHTUg1eEhuRWZETUFqanFTVG85cm1qZU5zLWZEN0JXanNNVnNXSHYtNE5LdXlrcTBpRnc5YXdTZ2l3S2NobXAtNkY0Z3dWTWFfWndGcU5QT0JmU2ZUNkNRa2F3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxOd1czMURoTDVhYjZSSFRDaFdIUEU1MjdxUUhIdXNaeU1IVUlvdU5RZFhtaHBHTUg1eEhuRWZETUFqanFTVG85cm1qZU5zLWZEN0JXanNNVnNXSHYtNE5LdXlrcTBpRnc5YXdTZ2l3S2NobXAtNkY0Z3dWTWFfWndGcU5QT0JmU2ZUNkNRa2F3?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-29T21:50:03+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Remains A Buy Heading Into Q3 Earnings (VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOSlp0b1RmSnk5X2V4N2YzZkhDSmdrakxJUkVfTlU3QUtSeVFuSjRtTVhncHg3eTVydThtZXBsMnVsel9EaUZRVzFXckY0T3RtbGQ2OThLS1FPUmVTckhNOV93aVg4bElQbENZRzdtQ3ltbTVRZXVWM0tQM3o3TGQ2TnRuZ0R6NE81aWdEMmh5SU8zLV9jOWZyNEdZaXJWd3FqTVhfbA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxOSlp0b1RmSnk5X2V4N2YzZkhDSmdrakxJUkVfTlU3QUtSeVFuSjRtTVhncHg3eTVydThtZXBsMnVsel9EaUZRVzFXckY0T3RtbGQ2OThLS1FPUmVTckhNOV93aVg4bElQbENZRzdtQ3ltbTVRZXVWM0tQM3o3TGQ2TnRuZ0R6NE81aWdEMmh5SU8zLV9jOWZyNEdZaXJWd3FqTVhfbA?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Remains A Buy Heading Into Q3 Earnings (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-10-28T15:59:33+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain. - Barron's",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barron's</font>",
      "published": "2025-10-31T05:30:00+00:00",
      "source": "Barron's"
    },
    {
      "title": "Lilly quietly cuts a pain drug from its pipeline - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPcHZhejM4X0wxd283ck5Pb2pmM0tocVQ5WE0wNFFIMHUyejZpNFI1SzdvamZmc2xTcDlOMEdPQjZlWWpfa20zclI0OEpVdE9TQWUwd0NCMjU1U0Z1dHQ3RGVUS0hDT19zMnFSVXlWWmRGVFlYdHZGLXNBVXRFZk5XX2R3SzQ0azVpVVJrM0pnclE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPcHZhejM4X0wxd283ck5Pb2pmM0tocVQ5WE0wNFFIMHUyejZpNFI1SzdvamZmc2xTcDlOMEdPQjZlWWpfa20zclI0OEpVdE9TQWUwd0NCMjU1U0Z1dHQ3RGVUS0hDT19zMnFSVXlWWmRGVFlYdHZGLXNBVXRFZk5XX2R3SzQ0azVpVVJrM0pnclE?oc=5\" target=\"_blank\">Lilly quietly cuts a pain drug from its pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-10-31T15:59:09+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Is Vertex Pharmaceuticals Incorporated stock a safe investment in uncertain markets - Weekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPam5QcjR1VzZOb0xsbXF3aXZDenk2M3hNdzNReExWdWhzM0Jkd2wxOUhIRGxBUlUwNVZPcjE3dEFXQ1d4RnlSSlZSZjQ2WmpmcHF3RUo1MTVmazQyclhycWJNa3RDdjlrZnFxZWx0RlQyWEZDcUdXWVBnRnVObUVaRlRjdlQwek5iN3VGUDU0TnNGWFRsRWNIU2R0VDZuSS1XV1llSzI0N1oydnd6dS1sck4yRlFQaDN0NVRv?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPam5QcjR1VzZOb0xsbXF3aXZDenk2M3hNdzNReExWdWhzM0Jkd2wxOUhIRGxBUlUwNVZPcjE3dEFXQ1d4RnlSSlZSZjQ2WmpmcHF3RUo1MTVmazQyclhycWJNa3RDdjlrZnFxZWx0RlQyWEZDcUdXWVBnRnVObUVaRlRjdlQwek5iN3VGUDU0TnNGWFRsRWNIU2R0VDZuSS1XV1llSzI0N1oydnd6dS1sck4yRlFQaDN0NVRv?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals Incorporated stock a safe investment in uncertain markets - Weekly Trade Analysis & Fast Exit and Entry Strategy Plans</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
      "published": "2025-10-31T08:44:06+00:00",
      "source": "newser.com"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks - NAI500",
      "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOSXljRWtwSG10bXo5blQ5cmdzODU4R09Ga3hFSEg3TkdHUkd0bWxXeFdSSkZGY3lYQ0k4d05PVVpzVmZkS1phVHVNRFdpUzFWczAzRC1McVUybHhSTnRKSldkOEtPXy1wRFE2cWtzLXZPalZhN196WHdxZE15MmZ1N2Vabld3WWE3OFVNU21yWEJwMmYzWkdZVHNZcUV5YVpsUS1qd2RMZjduX1MyVTJoNXhQcG1uMGhhMV9qX0NyZm11Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOSXljRWtwSG10bXo5blQ5cmdzODU4R09Ga3hFSEg3TkdHUkd0bWxXeFdSSkZGY3lYQ0k4d05PVVpzVmZkS1phVHVNRFdpUzFWczAzRC1McVUybHhSTnRKSldkOEtPXy1wRFE2cWtzLXZPalZhN196WHdxZE15MmZ1N2Vabld3WWE3OFVNU21yWEJwMmYzWkdZVHNZcUV5YVpsUS1qd2RMZjduX1MyVTJoNXhQcG1uMGhhMV9qX0NyZm11Zw?oc=5\" target=\"_blank\">It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NAI500</font>",
      "published": "2025-10-28T05:07:38+00:00",
      "source": "NAI500"
    },
    {
      "title": "Vertex Pharmaceuticals: Strong Buy Rating Backed by Promising Growth and Robust Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQTk1HVzdnU19YdXdOa2U5VWNKci15bndnTDRFLW1fSWxaUEdOb1UtVTh4TFhlRm1IZFh6b0FTOXpFQlR4N1YzdnVxRUhZRW1wMlBfSUlMVmNKVzhSZllkT05mRGtGNVdSWWhtNzlCZWFDS3VWekxNd0NmYkVWN3lpMkhGOHp2Qkp6Nm40ZFY0Ump3eGl1Ykl5OHhtNVVvdmpXREktZ2p1NWxvWG4yVzh0STlWNkxvUFFIMFR1VXBLQmFmaUo0WFhBLWZFU2s4dw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizgFBVV95cUxQTk1HVzdnU19YdXdOa2U5VWNKci15bndnTDRFLW1fSWxaUEdOb1UtVTh4TFhlRm1IZFh6b0FTOXpFQlR4N1YzdnVxRUhZRW1wMlBfSUlMVmNKVzhSZllkT05mRGtGNVdSWWhtNzlCZWFDS3VWekxNd0NmYkVWN3lpMkhGOHp2Qkp6Nm40ZFY0Ump3eGl1Ykl5OHhtNVVvdmpXREktZ2p1NWxvWG4yVzh0STlWNkxvUFFIMFR1VXBLQmFmaUo0WFhBLWZFU2s4dw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Buy Rating Backed by Promising Growth and Robust Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-27T13:45:26+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-10-31",
      "close": 425.57000732421875
    },
    "history": [
      {
        "date": "2025-10-23",
        "close": 422.6300048828125
      },
      {
        "date": "2025-10-24",
        "close": 421.3900146484375
      },
      {
        "date": "2025-10-27",
        "close": 420.1700134277344
      },
      {
        "date": "2025-10-28",
        "close": 422.3900146484375
      },
      {
        "date": "2025-10-29",
        "close": 417.2099914550781
      },
      {
        "date": "2025-10-30",
        "close": 419.8900146484375
      },
      {
        "date": "2025-10-31",
        "close": 425.57000732421875
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}